Alkem Laboratories Ltd.
Research Alkem Laboratories Ltd. (ALKEM.NS) on Bullrun: market cap INR 603.80B, P/E 28.0, dividend yield 1.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALKEM.NS
- ExchangeNSE
- CountryIndia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyINR
- Market capINR 603.80B
- P/E28.0
- Dividend yield1.1%
- Financial periodQ2 2026
- RevenueINR 37.40B
- Net incomeINR 5.20B
- Gross margin67.9%
Valuation Snapshot
latest market cap is INR 603.80B; P/E is 28.0; dividend yield is 1.1%.
Peer valuation comparison
Latest P/E is 27.99x versus a Healthcare sector median of 21.74x (28.7% above).
Latest dividend yield is 1.05% versus a Healthcare sector median of 2.4% (56.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 603.80B | 28.0 | 0.4% | 20 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 20 INR, yield 1.1%.
About Alkem Laboratories Ltd.
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Alkem Laboratories Ltd.'s market cap?
Alkem Laboratories Ltd.'s market capitalization is INR 603.80B.
What is Alkem Laboratories Ltd.'s P/E ratio?
Alkem Laboratories Ltd.'s price-to-earnings (P/E) ratio is 28.0.
Does Alkem Laboratories Ltd. pay a dividend?
Alkem Laboratories Ltd. has a dividend yield of 1.1%.
What does Alkem Laboratories Ltd. do?
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.